Nanox to Participate in the Virtual 31st Annual Oppenheimer Healthcare Conference
NANO-X IMAGING LTD (NASDAQ: NNOX) announces that CEO Ran Poliakine will present at the Oppenheimer 31st Annual Virtual Healthcare Conference from March 16-18, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
NANO-X IMAGING LTD (NASDAQ: NNOX) announces that CEO Ran Poliakine will present at the Oppenheimer 31st Annual Virtual Healthcare Conference from March 16-18, 2021. His presentation is scheduled for March 17 at 10:40am ET and will be available via a live webcast. Interested parties can access the presentation through the company’s website, with a replay available for 90 days afterward. Nanox aims to transform medical imaging with affordable solutions, promoting early detection through collaborations with leading healthcare organizations.
Details
News Market Reaction – NNOX
The recorded move for NNOX in the trading session of this news was +14.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEVE ILAN, Israel, March 15, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces that Nanox’s Founder and Chief Executive Officer Ran Poliakine will deliver a company presentation and the leadership team will host investor 1x1 meetings during the Oppenheimer 31st Annual Virtual Healthcare Conference, which is being held from March 16 through March 18.
Mr. Poliakine’s presentation is scheduled for Wednesday, March 17, at 10:40am ET. The presentation will be accessible via a live webcast at: https://wsw.com/webcast/oppenheimer9/nani/2701886
Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the company's website at www.nanox.vision. The webcast replay will be available after the conclusion of the live presentation for approximately 90 days.
About NANO-X:
Nano-X, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nano-X believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit www.nanox.vision.
Investors
Itzhak Maayan
Nanox Imaging
IR@nanox.vision
Bob Yedid
LifeSci Advisors
646-597-6989
bob@lifesciadvisors.com
Media
Alona Stein
ReBlonde for Nanox
alona@reblonde.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.